Brucellosis

Brucellosis is a highly contagious bacterial disease caused by various species of the genus Brucella, affecting multiple livestock species including cattle, sheep, goats, pigs, and wild ruminants such as bison and elk. This disease represents one of the most significant zoonotic infections worldwide, meaning it can be transmitted from animals to humans, causing serious public health concerns. In livestock, brucellosis primarily targets the reproductive system, leading to abortion, stillbirths, and infertility, while also affecting joints, the lymphatic system, and various internal organs. The disease has been recognized for centuries and continues to pose challenges to livestock producers and public health officials globally despite extensive eradication efforts.

The prevalence of brucellosis varies significantly by geographic region, with many developed countries having achieved brucellosis-free status through rigorous testing and eradication programs, while the disease remains endemic in parts of Africa, Asia, the Middle East, and Central and South America. In cattle, Brucella abortus is the primary causative agent, while Brucella melitensis affects sheep and goats, Brucella suis infects pigs, and Brucella ovis causes epididymitis in rams. Each species of Brucella demonstrates host preferences, though cross-species infection can occur under certain circumstances. The bacteria are remarkably resilient in the environment, surviving for extended periods in soil, water, manure, and animal products, which contributes to the difficulty of controlling outbreaks.

The economic impact of brucellosis on the livestock industry is substantial and multifaceted, encompassing direct losses from abortions, reduced milk production, decreased fertility, and premature culling of infected animals. Indirect costs include trade restrictions, testing and surveillance expenses, movement controls, and the administrative burden of regulatory compliance. Countries with endemic brucellosis face significant barriers to international livestock and animal product trade, as importing nations typically require certification of brucellosis-free status. The disease also creates considerable welfare concerns for affected animals, which may experience painful joint inflammation, reproductive complications, and chronic debilitation.

Brucellosis is classified as a reportable or notifiable disease in virtually all countries, meaning that suspected or confirmed cases must be reported to veterinary authorities. This regulatory status reflects the serious public health implications and the importance of disease surveillance for eradication efforts. Early detection is critical for controlling spread within herds and preventing human exposure. Treatment of brucellosis in livestock is generally not recommended or permitted due to the zoonotic risk and the difficulty of achieving complete bacterial elimination. Instead, control programs focus on vaccination of young animals, regular testing of breeding stock, and removal of infected animals from the herd through test-and-slaughter protocols.

Brucellosis is caused by gram-negative, facultative intracellular bacteria belonging to the genus Brucella. The primary species affecting livestock include Brucella abortus in cattle and bison, Brucella melitensis in sheep and goats, Brucella suis in pigs, and Brucella ovis specifically causing reproductive disease in rams. These bacteria are small, non-motile, non-spore-forming coccobacilli that can survive and replicate within host cells, particularly macrophages, which allows them to evade the immune system and establish chronic infections. The intracellular nature of Brucella organisms makes them particularly difficult to eliminate with antibiotics and contributes to the persistent nature of infections in affected animals.

Transmission of brucellosis occurs primarily through contact with infected reproductive tissues, fluids, and discharges. The bacteria are shed in massive quantities during abortion or normal parturition, with the placenta, fetal fluids, and vaginal discharges containing extremely high concentrations of organisms. Ingestion is the most common route of infection, with susceptible animals becoming infected by licking aborted fetuses, consuming contaminated feed or water, or grazing on pastures contaminated with infected reproductive materials. Venereal transmission can occur, particularly in species where males develop genital infections, and congenital transmission from infected dams to their offspring is well documented. The bacteria can also enter through mucous membranes of the eyes and through skin abrasions.

Environmental and management factors play significant roles in the spread and persistence of brucellosis. The bacteria can survive for extended periods outside the host, remaining viable for weeks to months in moist soil, water, manure, and aborted materials, especially in cool, shaded conditions. Intensive management systems with high animal density facilitate transmission through close contact and shared resources. Introduction of new animals without proper testing and quarantine is a major risk factor for herd infections. Wildlife reservoirs, particularly bison and elk in some regions, complicate eradication efforts by maintaining the pathogen in the ecosystem and potentially transmitting it to domestic livestock sharing grazing areas.

Certain risk factors increase individual animal and herd susceptibility to brucellosis infection. Sexually mature females are most vulnerable, particularly during pregnancy when the reproductive tract provides an ideal environment for bacterial multiplication. The presence of erythritol, a sugar alcohol found in high concentrations in the pregnant uterus of ruminants, promotes Brucella growth and tropism for reproductive tissues. Age influences susceptibility, with younger animals generally showing greater resistance to infection, which forms the basis for calfhood vaccination programs. Herd management practices such as communal calving areas, failure to properly dispose of aborted materials, and inadequate biosecurity measures increase infection risk.

The pathophysiology of brucellosis involves initial invasion through mucosal surfaces or skin, followed by uptake by macrophages and transport to regional lymph nodes. The bacteria replicate within phagocytic cells, eventually spreading via the bloodstream to establish infection in target organs including the reproductive tract, mammary gland, joints, and reticuloendothelial tissues. In pregnant animals, colonization of the placenta leads to placentitis, fetal infection, and abortion, typically occurring during the last trimester of pregnancy. The organism's ability to persist intracellularly allows it to establish chronic infection, with bacteria sequestered in tissues and intermittently shed, particularly during reproductive events.

Early warning signs of brucellosis in livestock herds are often subtle and may go unrecognized until significant disease spread has occurred. Initial indicators frequently include sporadic late-term abortions without obvious cause, particularly in animals bred for the first time or recently introduced to the herd. Retained placentas following normal calving or kidding may occur at higher than expected rates, and some animals may show decreased milk production or general malaise. Producers may notice reduced conception rates across the herd, with animals requiring multiple breeding attempts or failing to conceive despite apparently normal estrous cycles. These early reproductive abnormalities often precede more obvious clinical signs and represent critical opportunities for early detection through diagnostic testing.

The hallmark clinical sign of brucellosis in cattle, sheep, goats, and pigs is abortion, typically occurring during the last third of pregnancy. In cattle, abortions most commonly occur between the fifth and eighth month of gestation, though they can happen at any stage. Affected cows may abort without premonitory signs, or they may show mild depression, decreased appetite, and slight vaginal discharge in the days preceding abortion. The aborted fetus often appears fresh rather than decomposed, and the placenta typically shows characteristic changes including thickening, discoloration, and a leathery texture with necrotic cotyledons. Retained fetal membranes following abortion or full-term delivery are extremely common in brucellosis-infected animals, occurring in the majority of cases and predisposing to secondary metritis.

Behavioral changes associated with brucellosis include separation from the herd, reduced feed intake, and decreased activity levels. Infected animals may show reluctance to move or bear weight on affected limbs if joint involvement has developed. Cows with brucellosis-related metritis may exhibit straining, tail switching, and discomfort. Animals experiencing fever during the acute bacteremic phase may seek shade, reduce grazing time, and show decreased rumination. Social dynamics within the herd may shift as healthy animals avoid those with abnormal discharges or behaviors. Breeding males with genital infections may show decreased libido and reluctance to mount, affecting overall herd fertility.

Physical signs of brucellosis extend beyond reproductive manifestations to include joint swelling, particularly affecting the stifle, hip, and vertebral joints in cattle. Hygroma formation, the development of fluid-filled swellings over joints and tendon sheaths, is characteristic of chronic brucellosis and commonly affects the knee and hock regions. Bulls may develop orchitis and epididymitis, presenting as unilateral or bilateral testicular swelling with eventual atrophy of affected testicles. Mammary gland involvement can cause mastitis with altered milk composition. Lymph node enlargement, particularly of the supramammary, internal iliac, and retropharyngeal nodes, can be detected on physical examination or at slaughter inspection.

Symptom progression in brucellosis follows a pattern of acute infection followed by chronic persistence. Following initial exposure, there is typically an incubation period of several weeks to months before clinical signs appear. Acutely infected animals may show fever, depression, and reduced appetite during the bacteremic phase. The first pregnancy following infection usually results in abortion, with subsequent pregnancies often progressing normally despite continued infection, though bacteria are shed at each calving. Chronic infection leads to progressive joint damage, reduced fertility, and persistent bacterial shedding that poses ongoing transmission risk. Some animals become asymptomatic carriers, appearing clinically normal while harboring bacteria in tissues and intermittently shedding organisms.

Emergency symptoms requiring immediate veterinary intervention and regulatory notification include any abortion storm involving multiple animals in a short timeframe, which strongly suggests infectious etiology. Veterinary authorities must be contacted immediately when brucellosis is suspected, as this is a reportable disease with significant public health implications. Human exposure concerns constitute an emergency situation, particularly for individuals who have assisted with calving or abortion without adequate protection, handled potentially infected materials, or consumed unpasteurized dairy products from affected animals. Clinical signs suggesting acute bacteremia, including high fever, severe depression, and collapse, require urgent supportive care while diagnostic testing proceeds.

Clinical examination for brucellosis begins with a thorough history review including recent animal introductions, breeding and calving records, abortion incidence, and any previous testing results. Physical examination focuses on the reproductive system, joints, and lymph nodes, though clinical findings alone are insufficient for definitive diagnosis. Examination of aborted fetuses and placentas can reveal characteristic gross pathological changes, including fetal pneumonia, liver and spleen lesions, and placental necrosis. However, these findings are suggestive rather than diagnostic, and laboratory confirmation is essential given the regulatory and public health implications of brucellosis. Veterinarians must collect appropriate samples following strict biosafety protocols, recognizing the significant zoonotic risk associated with handling potentially infected materials.

Laboratory diagnosis of brucellosis relies on a combination of serological testing and direct detection methods. Serological tests detect antibodies against Brucella organisms and include screening tests such as the Rose Bengal Plate Test, Buffered Plate Antigen Test, and milk ring test for dairy herds. Positive screening results require confirmation through supplemental tests including the complement fixation test, competitive enzyme-linked immunosorbent assay, and fluorescence polarization assay. Culture of Brucella organisms from clinical samples including aborted fetuses, placenta, vaginal discharges, milk, semen, and tissues collected at necropsy provides definitive diagnosis. Polymerase chain reaction testing offers rapid molecular detection of Brucella DNA in clinical specimens. All diagnostic testing for brucellosis should be performed at approved laboratories with appropriate biosafety containment.

Differential diagnosis for brucellosis-associated abortion includes numerous other infectious and non-infectious causes that produce similar clinical presentations. Infectious differentials include bovine viral diarrhea, infectious bovine rhinotracheitis, leptospirosis, campylobacteriosis, trichomoniasis, neosporosis, and fungal placentitis. Non-infectious causes of abortion such as nutritional deficiencies, toxic plant ingestion, and heat stress must also be considered. In small ruminants, chlamydiosis, toxoplasmosis, and border disease enter the differential diagnosis alongside brucellosis. Joint swelling and lameness associated with brucellosis may mimic other infectious arthritides, trauma, and degenerative joint disease. Comprehensive diagnostic workup including appropriate sampling and testing is necessary to establish accurate diagnosis and implement appropriate control measures.

Herd-level diagnostic strategies form the foundation of brucellosis surveillance and eradication programs. Whole-herd testing using approved serological methods allows identification of infected animals and assessment of herd status. The frequency and type of testing depend on regulatory requirements, herd risk classification, and regional disease prevalence. Bulk tank milk testing provides efficient screening of dairy herds, with positive results triggering individual animal testing. Epidemiological investigation following detection of infected animals traces animal movements and identifies potential source herds and contact herds requiring testing. Slaughter surveillance through routine testing of blood collected at processing facilities provides population-level monitoring. Test interpretation must account for potential false-positive reactions due to vaccination or cross-reacting bacteria and false-negative results in early or chronic infections.

Treatment of brucellosis in food-producing livestock is generally not recommended, not attempted, or specifically prohibited by regulatory authorities in most jurisdictions. This policy reflects multiple considerations including the zoonotic nature of the disease, the difficulty of achieving complete bacterial elimination due to the intracellular location of organisms, the risk of creating antibiotic-resistant strains, food safety concerns regarding antibiotic residues, and the overriding goal of disease eradication rather than case management. Antimicrobial therapy might suppress clinical signs and reduce bacterial shedding temporarily but does not reliably eliminate infection, leaving treated animals as ongoing sources of transmission to other livestock and potential human exposure. The regulatory framework for brucellosis control mandates removal of infected animals rather than treatment attempts.

Immediate management upon suspicion or confirmation of brucellosis focuses on containment and prevention of further transmission while awaiting regulatory guidance. Suspected animals should be isolated from the main herd, particularly from pregnant animals and those with young offspring. Aborted materials, placentas, and contaminated bedding must be handled with extreme caution using appropriate personal protective equipment, then safely disposed of through burial or incineration. Contaminated areas require thorough cleaning and disinfection using approved agents effective against Brucella organisms. Movement of animals from the affected premises must cease pending regulatory investigation, and no animals should be sold, traded, or transported until authorized by veterinary officials.

Regulatory response to confirmed brucellosis typically involves a structured test-and-removal program administered by official veterinary services. All animals in the affected herd undergo serial testing at prescribed intervals, with positive reactors identified for mandatory slaughter. Depending on jurisdiction and circumstances, options may include depopulation of the entire herd, particularly when infection is widespread or tracing is impractical. Compensation programs may be available to offset producer losses from mandated animal removal. Movement restrictions remain in place until the herd demonstrates freedom from infection through consecutive negative whole-herd tests. Epidemiological investigation identifies potential source herds and traces downstream movements to identify contact herds requiring testing.

Supportive care may be provided to animals with acute illness while awaiting test results or regulatory disposition, focusing on symptomatic management without antimicrobial therapy. Animals with retained placentas require manual removal if possible, followed by uterine lavage and supportive treatment for metritis. Nutritional support ensures affected animals maintain body condition. Joint inflammation may be addressed with anti-inflammatory medications to improve comfort. Fluid therapy may be necessary for animals with significant dehydration from fever or reduced intake. However, any supportive interventions must not delay or interfere with regulatory testing and removal procedures, and milk from infected or suspect animals must not enter the food supply.

Herd treatment considerations in brucellosis outbreaks center on protecting uninfected animals and preventing establishment of endemic infection rather than treating infected individuals. Implementation of strict biosecurity measures limits transmission within the herd during the response period. Vaccination of eligible animals, typically young female calves, provides protection against future infection and reduces the likelihood of abortion in animals that do become infected. Strategic segregation of pregnant animals away from higher-risk individuals and environments reduces exposure risk during the vulnerable gestational period. Enhanced surveillance through increased testing frequency allows rapid identification and removal of newly infected animals.

Economic factors inevitably influence producer decisions during brucellosis outbreaks, though regulatory requirements ultimately determine permissible options. The financial impact of losing infected animals to mandatory slaughter can be devastating, particularly for valuable breeding stock or commercial herds facing high proportions of reactors. However, failure to comply with regulatory mandates results in legal consequences and perpetuates disease risk. Producers should work closely with veterinary officials and agricultural economists to understand available support programs, plan herd rebuilding strategies, and implement biosecurity improvements to prevent reintroduction. The long-term costs of endemic brucellosis, including ongoing reproductive losses, trade restrictions, and liability concerns, far exceed the short-term losses associated with aggressive eradication.

Recovery considerations for brucellosis differ fundamentally from those of most livestock diseases because individual animal recovery is not the management goal. Once an animal is confirmed infected with Brucella organisms, the standard response involves removal from the herd through slaughter rather than treatment and recovery. This approach recognizes that infected animals typically remain chronically infected and intermittently shed bacteria even if clinical signs resolve, posing ongoing transmission risk to other livestock and humans. Therefore, recovery discussion focuses primarily on herd recovery following identification and removal of infected animals, rehabilitation of the operation's disease status, and rebuilding of the breeding herd following depopulation or significant culling.

The timeline for herd recovery from brucellosis depends on the extent of infection, the control strategy implemented, and regulatory requirements for status restoration. Following removal of the last reactor animal, herds typically must complete a series of consecutive whole-herd tests at specified intervals, often requiring several months to over a year of negative testing before regaining brucellosis-free status. Incomplete depopulation requires more extensive testing to ensure detection of any remaining infected animals or those in the incubation period. Complete herd depopulation followed by thorough premises decontamination allows faster restocking but requires substantial upfront losses. The psychological and financial recovery period for producers often extends well beyond the formal regulatory timeline.

Post-outbreak monitoring and management involve ongoing vigilance to confirm disease elimination and prevent reintroduction. Continued surveillance testing according to regulatory schedules verifies maintenance of brucellosis-free status. Any animals showing reproductive problems should be investigated thoroughly with brucellosis testing included in diagnostic workups. Documentation of all testing, animal movements, and herd events supports regulatory compliance and facilitates any future investigations. Environmental decontamination of calving areas, equipment, and facilities reduces residual bacterial load. Wildlife interface management addresses potential reservoir species in areas where they pose a risk.

Prognosis for herd recovery is generally favorable when brucellosis is detected early before widespread herd infection, when regulatory programs are followed conscientiously, and when strong biosecurity measures prevent reintroduction. Herds in regions that have achieved area-wide brucellosis freedom face lower reintroduction risk than those in endemic areas or near wildlife reservoirs. Successful recovery requires producer commitment to testing protocols, biosecurity implementation, and vaccination programs. Return to normal production operations depends on regulatory status restoration, herd rebuilding progress, and market access recovery. Many operations successfully rebuild following brucellosis outbreaks, though the experience typically results in permanently enhanced awareness of biosecurity importance.

Vaccination represents a cornerstone of brucellosis prevention and control programs in many jurisdictions. Strain 19 vaccine, a live attenuated Brucella abortus preparation, has been used for decades in cattle and provides significant protection against infection and abortion. The vaccine is administered to heifer calves between 4 and 12 months of age to minimize interference with future serological testing and reduce the risk of vaccine-induced abortion. RB51 vaccine, a rough strain that does not induce antibodies detected by standard serological tests, offers an alternative that facilitates disease surveillance in vaccinated populations. Vaccination programs require veterinary administration and official documentation. In some brucellosis-free areas, vaccination may be discontinued or prohibited to facilitate disease detection through serosurveillance.

Biosecurity measures are essential for preventing brucellosis introduction and spread within livestock operations. A closed herd policy, avoiding purchase of outside animals, provides the strongest protection against disease introduction. When animal purchases are necessary, sourcing from certified brucellosis-free herds, requiring pre-purchase testing, and implementing quarantine with testing before introduction minimize risk. Fencing to prevent contact with neighboring livestock and wildlife reduces exposure to external sources of infection. Visitor management protocols, including restricted access to animal areas and provision of clean footwear and clothing, prevent mechanical transmission. Vehicle and equipment sanitation prevents transport of contaminated materials between premises.

Nutritional management supports immune function and reproductive health, contributing to brucellosis resistance. Adequate protein, energy, vitamin, and mineral nutrition maintains immune competence needed to resist infection following exposure. Trace mineral supplementation, particularly selenium, copper, and zinc, supports reproductive and immune function. Nutritional stress from inadequate feed quantity or quality compromises disease resistance and reproductive performance. Body condition management ensures animals enter breeding and gestation in appropriate nutritional status. While nutrition alone cannot prevent brucellosis infection, optimal nutritional management reduces susceptibility and improves overall herd health.

Management practices for brucellosis prevention focus on reproductive management, calving area hygiene, and herd health monitoring. Designated calving areas separate from general pastures allow better control of potentially contaminated materials. Prompt removal and proper disposal of placentas and aborted materials eliminates major sources of environmental contamination. Individual calving supervision enables immediate identification and investigation of abortion events. Reproductive record keeping facilitates detection of abnormal abortion patterns suggesting infectious disease. Regular veterinary herd health visits provide professional oversight and ensure appropriate diagnostic testing. Employee training in disease recognition, safe handling of reproductive materials, and reporting procedures ensures early detection.

Quarantine and testing protocols protect herds from introducing brucellosis through purchased or returning animals. All additions to the herd, regardless of source certification, should undergo quarantine isolation for a minimum of 30 days with testing before joining the main herd. Returning animals from shows, fairs, or leased pastures require similar quarantine and testing. Testing should include serological evaluation using approved methods, with interpretation by official veterinarians. Documentation of animal origin, test results, and quarantine periods provides evidence of due diligence. Relationships with reputable suppliers who maintain rigorous health programs reduce introduction risk. Participation in official disease-free certification programs provides additional assurance of herd status.

Daily management and monitoring for brucellosis prevention integrates disease awareness into routine livestock operations. Regular observation of animals during feeding, watering, and handling allows early detection of health abnormalities including reproductive problems, lameness, and behavioral changes. Particular attention to pregnant animals approaching parturition enables immediate response to abortion events. Documentation of all calvings, kiddings, or farrowings including outcomes and any complications supports pattern recognition. Designated personnel responsible for monitoring and reporting ensures accountability. Communication systems allow rapid notification of veterinary personnel when suspicious findings occur. Daily management decisions should consistently prioritize disease prevention alongside productivity goals.

Housing and environmental management significantly impact brucellosis transmission risk and overall herd health. Calving facilities should provide clean, dry environments with adequate space for individual animal monitoring and intervention. Regular cleaning and disinfection of maternity areas between uses removes potential contamination. Drainage systems prevent accumulation of fluids and waste materials. Proper manure management, including adequate storage time before land application, reduces environmental bacterial survival. Water sources should be protected from contamination by reproductive discharges and manure runoff. Housing designs that facilitate separation of different animal groups support quarantine and isolation needs.

Herd health programs provide structured approaches to disease prevention, detection, and management. Written health protocols developed in consultation with veterinarians establish standard procedures for vaccination, testing, biosecurity, and disease response. Scheduled veterinary visits for reproductive examinations, vaccinations, and diagnostic testing ensure regular professional evaluation. Participation in official brucellosis control and certification programs demonstrates commitment to disease freedom and facilitates market access. Integration of brucellosis prevention with broader herd health objectives, including control of other reproductive diseases, parasites, and metabolic conditions, optimizes resource utilization and animal wellbeing.

Record keeping and monitoring systems support brucellosis prevention and regulatory compliance. Individual animal identification using official tags, brands, or electronic devices enables accurate tracking throughout the animal's life. Breeding and reproduction records document service dates, pregnancy status, and calving outcomes. Health event records capture treatments, vaccinations, and diagnostic test results. Movement records track animal entries, departures, and internal transfers. Computerized record systems facilitate data analysis, trend identification, and report generation. Records should be maintained for periods specified by regulatory requirements and made available for official inspection. Good records support epidemiological investigation if disease is detected and demonstrate operational diligence.

Economic considerations influence brucellosis prevention investments and management decisions. Cost-benefit analysis of vaccination programs, testing protocols, and biosecurity infrastructure helps prioritize expenditures. Insurance options may provide some protection against losses from disease outbreaks. Marketing strategies emphasizing health status may command premium prices for breeding stock. Long-term planning should account for potential regulatory changes, market access requirements, and evolving disease risks. Investment in prevention typically provides superior returns compared to outbreak response costs, including animal losses, trade disruptions, and regulatory compliance expenses. Financial planning for disease events, including liquidity reserves and credit arrangements, prepares operations for unexpected challenges.

Brucellosis affects all breeds of susceptible livestock species without clear breed-specific resistance or susceptibility patterns established in cattle, sheep, goats, or pigs. However, certain populations face elevated exposure risk based on management systems, geographic location, and wildlife interface rather than genetic factors. Beef cattle breeds managed on extensive rangelands in areas with endemic wildlife reservoirs, such as bison and elk in parts of North America, experience greater exposure risk than breeds typically raised in intensive systems. Dairy breeds face different risk profiles related to herd management intensity, animal movement patterns, and milk handling practices. Heritage and rare breeds maintained in conservation programs may have limited testing history and uncertain status.

Production type significantly influences brucellosis exposure and consequences more than breed genetics. Commercial dairy operations with frequent animal movements, bulk milk collection, and intensive management face different risk dynamics than closed cow-calf beef operations. Seedstock producers moving breeding animals between operations and to sales create potential transmission pathways regardless of breed. Feedlot cattle populations aggregate animals from multiple sources, though the non-breeding nature of feedlot production limits reproductive disease manifestation. Sheep and goat operations vary from large commercial rangeland flocks to small diversified farms, with differing biosecurity capabilities and wildlife exposure. Swine operations range from intensive confinement systems with high biosecurity to outdoor heritage breed production with greater environmental exposure.

Genetic selection and testing for brucellosis resistance is not currently practiced as a significant control strategy, given the effectiveness of vaccination and test-and-removal programs in susceptible populations. Research has identified some genetic variation in resistance to Brucella infection and disease manifestation, but this variation is not consistently associated with specific breeds or readily incorporated into breeding programs. Genetic improvement efforts in livestock focus on economically important production traits rather than brucellosis resistance. Selection for general disease resistance and immune function may provide indirect benefits. The primary genetic consideration in brucellosis control involves maintaining accurate pedigree and identification records to support epidemiological investigation and trace infected animals to source populations.

Brucellosis frequently coexists with other reproductive diseases in livestock populations, complicating diagnosis and compounding economic losses. Leptospirosis, caused by Leptospira bacteria, produces similar abortion and infertility syndromes and may occur alongside brucellosis in the same herds. Campylobacteriosis and trichomoniasis cause venereal disease with reproductive failure that must be differentiated from brucellosis. Bovine viral diarrhea and infectious bovine rhinotracheitis are viral causes of abortion requiring consideration in any reproductive disease investigation. Neosporosis, a protozoal infection, has emerged as a major cause of bovine abortion globally. Comprehensive reproductive disease investigation addresses multiple potential causes rather than assuming single-disease etiology.

Several conditions produce clinical signs similar to brucellosis, requiring careful differential diagnosis. Joint swelling and lameness from Mycoplasma infections, traumatic injuries, or other infectious arthritides may mimic brucellosis-associated joint disease. Orchitis and epididymitis in bulls can result from various bacterial infections besides Brucella. Retained placenta and metritis follow dystocia and other calving complications regardless of infectious etiology. Abortion storms may result from nutritional deficiencies, toxic exposures, or management stressors rather than infectious agents. Serological cross-reactions with Yersinia enterocolitica O:9 and certain other bacteria can complicate brucellosis diagnosis. Veterinary investigation must consider the full range of differential diagnoses.

Complications and sequelae of brucellosis extend the disease impact beyond initial reproductive losses. Chronic joint disease may develop in animals surviving initial infection, causing persistent lameness and reduced productivity. Infertility resulting from reproductive tract damage may be permanent, requiring premature culling of valuable breeding animals. Orchitis progressing to testicular atrophy renders bulls unsuitable for breeding. Metritis secondary to retained placenta predisposes to subsequent reproductive failure. Mammary gland infection can cause chronic mastitis with persistent milk quality problems. Human infection acquired from animal contact represents the most serious consequence, causing debilitating illness requiring prolonged antibiotic therapy. All complications underscore the importance of prevention and prompt removal of infected animals.